Aehr Test Systems (AEHR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
| 11-2020 | 08-2020 | 05-2020 | 02-2020 | 11-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,859 | 107 | -2,802 | 83 | -162 |
| Depreciation Amortization | 165 | 82 | 384 | 298 | 193 |
| Accounts receivable | 2,341 | 2,642 | 1,161 | 1,360 | -372 |
| Accounts payable and accrued liabilities | 160 | -173 | -1,024 | -1,033 | 389 |
| Other Working Capital | 1,313 | 2,585 | -561 | -1,630 | -711 |
| Other Operating Activity | -4,375 | -4,600 | 818 | 282 | 387 |
| Operating Cash Flow | $-2,255 | $643 | $-2,024 | $-640 | $-276 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -194 | -47 | -163 | -149 | -123 |
| Investing Cash Flow | $-194 | $-47 | $-163 | $-149 | $-123 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 1,679 | N/A | N/A |
| Common Stock Issued | 365 | 190 | 493 | 423 | 293 |
| Financing Cash Flow | $365 | $190 | $2,172 | $423 | $293 |
| Exchange Rate Effect | 100 | 94 | 20 | -4 | -20 |
| Beginning Cash Position | 5,513 | 5,513 | 5,508 | 5,508 | 5,508 |
| End Cash Position | 3,529 | 6,393 | 5,513 | 5,138 | 5,382 |
| Net Cash Flow | $-1,984 | $880 | $5 | $-370 | $-126 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,255 | 643 | -2,024 | -640 | -276 |
| Capital Expenditure | -194 | -47 | -163 | -151 | -123 |
| Free Cash Flow | -2,449 | 596 | -2,187 | -791 | -399 |